ArticleAntimicrobial agents and chemotherapy2004

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

D J Tenney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.